Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Autologous bone marrow transplantation for adult acute leukemia
E. D. Ball,
W. B. Rybka
Department of Medicine
Division of Hematology and Oncology
Penn State Cancer Institute
Cancer Institute, Next-Generation Therapies
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Autologous bone marrow transplantation for adult acute leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
100%
Allogeneic Bone Marrow Transplantation
100%
Adult Acute Lymphoblastic Leukemia
100%
Curative Treatment
66%
Purging
33%
Clinical Trials
33%
Well-defined
33%
Adjunctive Therapy
33%
High Risk
33%
Randomized Clinical Trial
33%
Improved Survival
33%
Interleukin-2
33%
Acute Leukemia
33%
Remission
33%
Extended Period
33%
Preparative Regimen
33%
Adverse Cytogenetics
33%
Relative Value
33%
Chemotherapy Alone
33%
Allogeneic BMT
33%
Risk for Relapse
33%
Medicine and Dentistry
Acute Myelogenous Leukemia
100%
Acute Leukemia
100%
Autologous Bone Marrow Transplantation
100%
Acute Lymphocytic Leukemia
80%
Health Care Cost
20%
Clinical Trial
20%
Adjuvant Therapy
20%
Randomized Clinical Trial
20%
Interleukin 2
20%
Population
20%
Nursing and Health Professions
Acute Leukemia
100%
Adjuvant Therapy
50%
Population
50%
Remission
50%
Interleukin 2
50%
Treatment Failure
50%
Pharmacology, Toxicology and Pharmaceutical Science
Secondary Acute Myeloid Leukemia
25%